Related Experiment Video
Updated: May 6, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
When the meningitis-encephalitis panel is negative: off-label joint infection PCR detects CTX-M ESBL-producing
Márk Kozák1, Levente Majoros2, Ferenc Bodnár2
1Department of Infectology, Faculty of Medicine, University of Debrecen, 2-26 Bartok Bela Street, Debrecen, 4031, Hungary. kozak.mark@med.unideb.hu.
Abstract:
Spontaneous Gram-negative bacillary meningitis in adults is rare and carries high mortality, particularly in elderly patients with significant comorbidities. Although multiplex meningitis-encephalitis (ME) panels have improved diagnostic turnaround time, their limited pathogen spectrum may reduce sensitivity for certain clinically relevant Gram-negative organisms. We report a 78-year-old man presenting with acute meningoencephalitis, septic deterioration, and cerebrospinal fluid (CSF) findings strongly suggestive of bacterial infection. Despite marked neutrophilic pleocytosis and elevated protein levels, the multiplex ME panel was negative. Blood cultures subsequently yielded Proteus mirabilis. Given the discordance between inflammatory CSF findings and routine molecular testing, following interdisciplinary consultation, an off-label BioFire® Joint Infection multiplex PCR panel was performed directly on CSF. The assay identified Proteus mirabilis harboring a cefotaximase-Munich (CTX-M)-type extended-spectrum β-lactamase (ESBL) resistance determinant. Based on this result, antimicrobial therapy was escalated from ceftriaxone-based empiric treatment to meropenem prior to availability of phenotypic susceptibility data. Despite early pathogen identification and targeted antimicrobial therapy, the patient died due to multiorgan dysfunction secondary to severe sepsis. This case suggests a potential diagnostic limitation of standard ME panels in selected high-risk scenarios and indicates that selective off-label use of broader multiplex PCR platforms may provide additional clinically relevant information in carefully selected patients. In the setting of high clinical suspicion and negative routine multiplex testing, rapid resistance-gene detection may provide actionable information within a decisive therapeutic window and support timely antimicrobial optimization in severe Gram-negative central nervous system infections. Further studies are required to evaluate the diagnostic performance and clinical impact of such approaches. Written informed consent for publication was obtained from the patient's next of kin, and the study was conducted in accordance with institutional and ethical standards.Clinical trial number Not applicable.
Insights
Standard multiplex meningitis panels may miss rare Gram-negative bacteria, like Proteus mirabilis, in elderly patients. Off-label PCR use on cerebrospinal fluid identified resistance genes, aiding treatment, though the patient unfortunately died.
Area of Science:
- Infectious Diseases
- Neurology
- Clinical Microbiology
Background:
- Spontaneous Gram-negative bacillary meningitis is rare but deadly, especially in elderly patients with comorbidities.
- Standard multiplex meningitis-encephalitis (ME) panels may have limited sensitivity for certain Gram-negative pathogens.
- Early diagnosis and targeted treatment are crucial for improving outcomes in bacterial meningitis.
Purpose of the Study:
- To report a case of Gram-negative meningitis missed by standard ME panels.
- To highlight the potential utility of off-label multiplex PCR in diagnosing difficult cases.
- To emphasize the importance of rapid resistance gene detection for antimicrobial optimization.
Main Methods:
- A case report of a 78-year-old male with acute meningoencephalitis.
- Initial diagnosis using cerebrospinal fluid (CSF) analysis and standard multiplex ME panel.
- Subsequent off-label use of a multiplex PCR panel for joint infections directly on CSF.
- Blood cultures for pathogen identification and resistance gene detection.
Main Results:
- CSF analysis showed inflammation, but the standard ME panel was negative.
- Blood cultures identified Proteus mirabilis.
- Off-label CSF PCR detected Proteus mirabilis with an extended-spectrum β-lactamase (ESBL) resistance gene (CTX-M).
- Antimicrobial therapy was escalated to meropenem based on PCR results before susceptibility data.
Conclusions:
- Standard ME panels may fail to detect certain Gram-negative pathogens in meningitis.
- Off-label use of broader multiplex PCR panels can provide critical diagnostic information in select cases.
- Rapid resistance gene detection in CSF can guide timely antimicrobial escalation in severe Gram-negative CNS infections, despite a fatal outcome in this case.
More Related Videos
Related Concept Videos
Bacterial Meningitis I: Introduction
Viral Meningitis
Atypical Pneumonia
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Pneumonia III: Complications and Assessment

